Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Guba

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
European Journal of Clinical Investigation|May 29, 2013
Neutrophil gelatinase-associated lipocalin and end-stage renal disease: it is not all about the kidneys!Simon Rau, Antje Habicht, Teresa Kauke, et al.
Plos One|April 17, 2018
Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 monthsSebastian Wolf, Verena S Hoffmann, Antje Habicht, et al.
The Lancet. Oncology|March 4, 2021
The role of radiotherapy in patients with solid tumours after solid organ transplantation: a systematic reviewRosario Mazzola, Francesco Cuccia, Alessandro Bertani, et al.
EJNMMI Research|January 24, 2012
99mTc-MAG3 scintigraphy for the longitudinal follow-up of kidney function in a mouse model of renal ischemia-reperfusion injuryTanja Herrler, Hao Wang, Anne Tischer, et al.
European Journal of Gastroenterology & Hepatology|November 7, 2015
Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcomeAndrej Khandoga, Emil Iskandarov, Martin Angele, et al.
International Journal of Surgery (London, England)|September 27, 2021
Patient expectations shape convalescence after major liver surgery - A prospective, randomized studyNikolaus Börner, Maximilian Weniger, Julia Nossek, et al.
Oncology Reports|August 9, 2002
Elevated MIA serum levels are predictors of poor prognosis after surgical resection of metastatic malignant melanomaMarkus Guba, Markus Steinbauer, Verena Ruhland, et al.
Transplant Immunology|May 2, 2017
Antibody response to HBV vaccination on dialysis does not correlate with the development of deNovo anti-HLA antibodies after renal transplantationTeresa Kauke, Maximilian Link, Markus Rentsch, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 23, 2004
Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancerMarkus Guba, Gudrun E Koehl, Evelyn Neppl, et al.
Transplantation|December 28, 2012
Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysisJoachim Andrassy, Verena S Hoffmann, Markus Rentsch, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
European Journal of Clinical Investigation|May 29, 2013
Neutrophil gelatinase-associated lipocalin and end-stage renal disease: it is not all about the kidneys!Simon Rau, Antje Habicht, Teresa Kauke, et al.
Plos One|April 17, 2018
Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 monthsSebastian Wolf, Verena S Hoffmann, Antje Habicht, et al.
The Lancet. Oncology|March 4, 2021
The role of radiotherapy in patients with solid tumours after solid organ transplantation: a systematic reviewRosario Mazzola, Francesco Cuccia, Alessandro Bertani, et al.
EJNMMI Research|January 24, 2012
99mTc-MAG3 scintigraphy for the longitudinal follow-up of kidney function in a mouse model of renal ischemia-reperfusion injuryTanja Herrler, Hao Wang, Anne Tischer, et al.
European Journal of Gastroenterology & Hepatology|November 7, 2015
Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcomeAndrej Khandoga, Emil Iskandarov, Martin Angele, et al.
International Journal of Surgery (London, England)|September 27, 2021
Patient expectations shape convalescence after major liver surgery - A prospective, randomized studyNikolaus Börner, Maximilian Weniger, Julia Nossek, et al.
Oncology Reports|August 9, 2002
Elevated MIA serum levels are predictors of poor prognosis after surgical resection of metastatic malignant melanomaMarkus Guba, Markus Steinbauer, Verena Ruhland, et al.
Transplant Immunology|May 2, 2017
Antibody response to HBV vaccination on dialysis does not correlate with the development of deNovo anti-HLA antibodies after renal transplantationTeresa Kauke, Maximilian Link, Markus Rentsch, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 23, 2004
Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancerMarkus Guba, Gudrun E Koehl, Evelyn Neppl, et al.
Transplantation|December 28, 2012
Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysisJoachim Andrassy, Verena S Hoffmann, Markus Rentsch, et al.
Pageof 15